AR059088A1 - Administracion intraventricular de una proteina para esclerosis lateral amiotrofica - Google Patents
Administracion intraventricular de una proteina para esclerosis lateral amiotroficaInfo
- Publication number
- AR059088A1 AR059088A1 ARP070100238A ARP070100238A AR059088A1 AR 059088 A1 AR059088 A1 AR 059088A1 AR P070100238 A ARP070100238 A AR P070100238A AR P070100238 A ARP070100238 A AR P070100238A AR 059088 A1 AR059088 A1 AR 059088A1
- Authority
- AR
- Argentina
- Prior art keywords
- lateral sclerosis
- protein
- intraventricular administration
- amiotrophic lateral
- amyotrophic lateral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La esclerosis lateral amiotrofica puede tratarse exitosamente usando la aplicacion intraventricular de un factor de crecimiento neurotrofico, IGF-1. La administracion puede realizarse lentamente para lograr el efecto máximo. Los efectos pueden observarse en ambos lados de la barrera sangre-cerebro, por lo cual este medio de aplicacion para esclerosis lateral amiotrofica afecta a ambos, el cerebro y el musculo esquelético.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76037706P | 2006-01-20 | 2006-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR059088A1 true AR059088A1 (es) | 2008-03-12 |
Family
ID=38288299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070100238A AR059088A1 (es) | 2006-01-20 | 2007-01-19 | Administracion intraventricular de una proteina para esclerosis lateral amiotrofica |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090105141A1 (es) |
EP (1) | EP1986680A4 (es) |
JP (1) | JP2009523819A (es) |
CN (1) | CN101443029A (es) |
AR (1) | AR059088A1 (es) |
BR (1) | BRPI0706694A2 (es) |
CA (1) | CA2636438A1 (es) |
IL (1) | IL192678A0 (es) |
RU (1) | RU2008134118A (es) |
WO (1) | WO2007084743A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR059089A1 (es) | 2006-01-20 | 2008-03-12 | Genzyme Corp | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal |
CA3168881A1 (en) * | 2006-02-09 | 2007-08-23 | Genzyme Corporation | Slow intraventricular delivery |
BRPI0910338A2 (pt) * | 2008-04-03 | 2020-08-18 | F. Hoffmann-La Roche Ag | uso de variantes peguiladas de igf-i para o tratamento de distúbios neuromusculares |
US10140708B2 (en) * | 2016-01-21 | 2018-11-27 | Riverside Research Institute | Method for gestational age estimation and embryonic mutant detection |
US20210198312A1 (en) * | 2019-12-31 | 2021-07-01 | Helena Lovick | Growth factor concentrate and method of manufacture thereof |
WO2023242442A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Method of maturing/differentiating neurons and/or modulating the vagus nerve |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8303626D0 (sv) * | 1983-06-23 | 1983-06-23 | Kabigen Ab | A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced |
SE8703625D0 (sv) * | 1987-09-18 | 1987-09-18 | Kabivitrum Ab | New medical use |
AU4318496A (en) * | 1994-12-21 | 1996-07-10 | Auckland Uniservices Limited | Enhancement of fetal growth by administration of insulin-likegrowth factor-1(IGF-1) |
WO1997039789A1 (en) * | 1996-04-22 | 1997-10-30 | Medtronic, Inc. | Two-stage angled venous cannula |
US6042579A (en) * | 1997-04-30 | 2000-03-28 | Medtronic, Inc. | Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain |
WO2005072049A2 (en) * | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
-
2007
- 2007-01-19 AR ARP070100238A patent/AR059088A1/es not_active Application Discontinuation
- 2007-01-22 WO PCT/US2007/001599 patent/WO2007084743A2/en active Application Filing
- 2007-01-22 RU RU2008134118/15A patent/RU2008134118A/ru not_active Application Discontinuation
- 2007-01-22 JP JP2008551446A patent/JP2009523819A/ja not_active Withdrawn
- 2007-01-22 BR BRPI0706694-5A patent/BRPI0706694A2/pt not_active IP Right Cessation
- 2007-01-22 CA CA002636438A patent/CA2636438A1/en not_active Abandoned
- 2007-01-22 CN CNA2007800027784A patent/CN101443029A/zh active Pending
- 2007-01-22 EP EP07718156A patent/EP1986680A4/en not_active Withdrawn
-
2008
- 2008-07-08 IL IL192678A patent/IL192678A0/en unknown
- 2008-07-18 US US12/175,870 patent/US20090105141A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2636438A1 (en) | 2007-07-26 |
RU2008134118A (ru) | 2010-02-27 |
IL192678A0 (en) | 2011-08-01 |
WO2007084743A3 (en) | 2008-11-27 |
EP1986680A2 (en) | 2008-11-05 |
BRPI0706694A2 (pt) | 2011-04-05 |
EP1986680A4 (en) | 2010-12-08 |
WO2007084743A2 (en) | 2007-07-26 |
JP2009523819A (ja) | 2009-06-25 |
US20090105141A1 (en) | 2009-04-23 |
CN101443029A (zh) | 2009-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR059088A1 (es) | Administracion intraventricular de una proteina para esclerosis lateral amiotrofica | |
GB2437639B (en) | Privacy enhanced identity scheme using an un-linkable identifier | |
CR10245A (es) | "nuevas combinaciones terapéuticas para el tratamiento de la depresión" | |
DE602005001512D1 (de) | System zur intravenösen Verabreichung | |
CR20110221A (es) | Terapia de combinación con péptidos epoxicetonas peptídicas | |
ATE537844T1 (de) | Dauerhafte lokalanästhetische zusammensetzung mit saib | |
DE602005000278D1 (de) | Common-Rail Injektor | |
ECSP10010007A (es) | Tratamiento con ligandos alpha-7-selectivos | |
ITTO20050525A1 (it) | Lembi perfezionati per ridurre gli effetti dannosi dei detriti. | |
TWI377955B (en) | Processes for preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid | |
ITMI20040076A1 (it) | Procedimento per la preparazione di polibutadiene a basso grado di ranificazione | |
AP2011005681A0 (en) | Methods and formulations for treating chronic liver disease. | |
HK1125305A1 (en) | Methods for treating viral infections using polyamine analogs | |
EP2208498B8 (en) | Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency | |
ITMI20080570A1 (it) | Procedimento per la preparazione di polibutadiene ramificato ad alto contenuto in unita' 1,4-cis | |
WO2007122382A3 (en) | Lycopene for the treatment of metabolic dysfunction | |
AT500095B1 (de) | Transdermales abgabesystem | |
DE502006001195D1 (de) | Transdermales therapeutisches system zur verabreichung von analgetika | |
GB0607849D0 (en) | Tank-refilling pump arrangements | |
DE602006009482D1 (de) | Motors abhängig von der Fahrtüchtigkeit | |
CL2008003933A1 (es) | Compuestos derivados de n-heterociclo-[1,2-a]-piridina-2-carboxamida; procedimiento de preparacion; composicion farmaceutica; utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas, inflamatorias, epilepsia, osteoporosis, tumores malignos, entre otras. | |
DK2041128T3 (da) | Substituerede gamma-lactamer som terapeutiske agenser | |
BRPI0810682A2 (pt) | agente antitumoral em especial para o tratamento de tumores dérmicos, fármaco, kit compreendendo fármaco. | |
DE502005007830D1 (de) | Common-Rail-Injektor | |
ES2389424B1 (es) | Procedimiento para la visualizacion de superficies en el cuerpo humano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |